Search research articles
Contact Us
Filters
Showing results (451-460 of 571) with videos related to
Page
of 58
Sort By:
Biorxiv : the Preprint Server for Biology
|
September 24, 2024
A Comprehensive Proteogenomic and Spatial Analysis of Innate and Acquired Resistance of Metastatic Melanoma to Immune Checkpoint Blockade Therapies
Shiyou Wei, Kuang Du, Hongbin Lan, et al.
Histopathology
|
June 4, 2014
Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic value
Elizabeth G Demicco, Genevieve M Boland, Kari J Brewer Savannah, et al.
Cancer Medicine
|
January 8, 2024
Recurrence-free survival dynamics following adjuvant chemotherapy for resected colorectal cancer: A systematic review of randomized controlled trials
Emma Vail, Ankur P Choubey, H Richard Alexander, et al.
The Journal of Clinical Investigation
|
February 24, 2015
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma
Lawrence N Kwong, Genevieve M Boland, Dennie T Frederick, et al.
NPJ Precision Oncology
|
March 2, 2023
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
Douglas B Fox, Richard Y Ebright, Xin Hong, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
Attomolar fecal cytokine profiling reveals gut immune dynamics and disease states
Stephanie J Zhang, Utkarsh Sharma, Yasmeen Senussi, et al.
Physical Therapy
|
February 20, 2016
Dietary Protein Intake and Lean Muscle Mass in Survivors of Childhood Acute Lymphoblastic Leukemia: Report From the St. Jude Lifetime Cohort Study
Alexandra M Boland, Todd M Gibson, Lu Lu, et al.
Journal of Gastrointestinal Oncology
|
January 24, 2022
Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three-week course chemoradiotherapy using capecitabine-based versus gemcitabine-based concurrent chemotherapy
Shane S Neibart, Swati Mamidanna, Anupama Chundury, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 21, 2020
Targeting the cyclin-dependent kinase 5 in metastatic melanoma
Samanta Sharma, Tian Zhang, Wojciech Michowski, et al.
JAMA Network Open
|
February 18, 2022
Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer: A Randomized Clinical Trial
Niharika B Mettu, Fang-Shu Ou, Tyler J Zemla, et al.
Page
of 58
Search research articles
Search
Showing results (451-460 of 571) with videos related to
Sort By:
Page
of 58
Biorxiv : the Preprint Server for Biology
|
September 24, 2024
A Comprehensive Proteogenomic and Spatial Analysis of Innate and Acquired Resistance of Metastatic Melanoma to Immune Checkpoint Blockade Therapies
Shiyou Wei, Kuang Du, Hongbin Lan, et al.
Histopathology
|
June 4, 2014
Progressive loss of myogenic differentiation in leiomyosarcoma has prognostic value
Elizabeth G Demicco, Genevieve M Boland, Kari J Brewer Savannah, et al.
Cancer Medicine
|
January 8, 2024
Recurrence-free survival dynamics following adjuvant chemotherapy for resected colorectal cancer: A systematic review of randomized controlled trials
Emma Vail, Ankur P Choubey, H Richard Alexander, et al.
The Journal of Clinical Investigation
|
February 24, 2015
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma
Lawrence N Kwong, Genevieve M Boland, Dennie T Frederick, et al.
NPJ Precision Oncology
|
March 2, 2023
Downregulation of KEAP1 in melanoma promotes resistance to immune checkpoint blockade
Douglas B Fox, Richard Y Ebright, Xin Hong, et al.
Biorxiv : the Preprint Server for Biology
|
April 10, 2026
Attomolar fecal cytokine profiling reveals gut immune dynamics and disease states
Stephanie J Zhang, Utkarsh Sharma, Yasmeen Senussi, et al.
Physical Therapy
|
February 20, 2016
Dietary Protein Intake and Lean Muscle Mass in Survivors of Childhood Acute Lymphoblastic Leukemia: Report From the St. Jude Lifetime Cohort Study
Alexandra M Boland, Todd M Gibson, Lu Lu, et al.
Journal of Gastrointestinal Oncology
|
January 24, 2022
Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three-week course chemoradiotherapy using capecitabine-based versus gemcitabine-based concurrent chemotherapy
Shane S Neibart, Swati Mamidanna, Anupama Chundury, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 21, 2020
Targeting the cyclin-dependent kinase 5 in metastatic melanoma
Samanta Sharma, Tian Zhang, Wojciech Michowski, et al.
JAMA Network Open
|
February 18, 2022
Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer: A Randomized Clinical Trial
Niharika B Mettu, Fang-Shu Ou, Tyler J Zemla, et al.
Page
of 58